| Bioactivity | 8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide (compound 3), a sesquiterpene, has anti-LIMK1 activity. 8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide has inhibitory property on cell motility[1]. |
| Name | 8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide |
| CAS | 956707-04-3 |
| Formula | C15H18O4 |
| Molar Mass | 262.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jianjiang Fu, et al. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Phytomedicine. 2018 Oct 1;49:23-31. |
8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide
CAS: 956707-04-3 F: C15H18O4 W: 262.30
8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide (compound 3), a sesquiterpene, has anti-LIMK1 activity. 8β,9α-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.